08045804946
medisus.pharma007@gmail.com
Change Language
PERZEA 420MG PERZEA 420MG PERZEA 420MG
PERZEA 420MG
PERZEA 420MG PERZEA 420MG

PERZEA 420MG

24999.0 INR/Box

Product Details:

  • Origin of Medicine INDIA
  • Drug Type Injection
  • Ingredients Active IngredientPertuzumab: \(420\text{ mg}\) per \(14\text{ mL}\) vial (concentration of \(30\text{ mg/mL}\)). It is a humanized monoclonal antibody produced via recombinant DNA technology in mammalian (Chinese hamster ovary) cells.Inactive Ingredients (Excipients)Glacial acetic acid: Helps maintain a stable, optimal pH for the solution.L-Histidine: An amino acid that acts as a buffering agent to stabilize the protein.Sucrose: A sugar used as a cryoprotectant to protect the antibodies during storage.Polysorbate 20: A surfactant that prevents the antibody from aggregating or sticking to the vial surfaces.Water for injections: The sterile liquid solvent used to dissolve and dilute the ingredients.
  • Physical Form Liquid
  • Dosage 420
  • Suitable For Women, Adults
  • Quantity 1 Boxes
  • Click to View more
X

PERZEA 420MG Price And Quantity

  • 10 Box
  • 24999.0 INR/Box

PERZEA 420MG Product Specifications

  • Liquid
  • 420
  • Women, Adults
  • Injection
  • Active IngredientPertuzumab: \(420\text{ mg}\) per \(14\text{ mL}\) vial (concentration of \(30\text{ mg/mL}\)). It is a humanized monoclonal antibody produced via recombinant DNA technology in mammalian (Chinese hamster ovary) cells.Inactive Ingredients (Excipients)Glacial acetic acid: Helps maintain a stable, optimal pH for the solution.L-Histidine: An amino acid that acts as a buffering agent to stabilize the protein.Sucrose: A sugar used as a cryoprotectant to protect the antibodies during storage.Polysorbate 20: A surfactant that prevents the antibody from aggregating or sticking to the vial surfaces.Water for injections: The sterile liquid solvent used to dissolve and dilute the ingredients.
  • INDIA
  • 1 Boxes

Product Description

Actionable & Authoritative Resources
For detailed prescribing information, dosage guidelines, and patient resources, consult these authoritative platforms:
Key Characteristics
  • Mechanism of Action: Pertuzumab binds to a specific site on the HER2 receptor (subdomain II). This prevents the HER2 protein from pairing (dimerizing) with other HER receptors, ultimately stopping the cancer cells from growing and multiplying.
  • Dosage Schedule: The 420 mg strength serves as a maintenance dose. It is typically administered after an initial 840 mg loading dose. The maintenance infusion takes 30 to 60 minutes and is repeated every 3 weeks.
  • Indications: Used in early-stage HER2-positive breast cancer (before or after surgery) and metastatic HER2-positive breast cancer.
  • Side Effects: Common side effects include diarrhea, hair loss (alopecia), nausea, fatigue, and a decrease in certain white blood cells (neutropenia). It may also cause infusion-related reactions and heart function issues (e.g., left ventricular dysfunction). 
Important Safety Information
  • Pregnancy Risk: Pertuzumab can cause embryo-fetal toxicity and birth defects. It is not recommended during pregnancy. Effective contraception must be used during treatment and for at least 6 months after the final dose.
  • Heart Monitoring: Because of the risk of heart muscle damage, healthcare providers routinely monitor heart function before and during treatment.
  • Administration: This medication must only be prepared and administered by a qualified healthcare professional in a clinical setting.
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Medicines' category



Back to top